![miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer](https://www.oncotarget.net/wp-content/uploads/2024/08/Screen-Shot-2024-08-27-at-2.54.21-PM-300x120.png)
miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer
August 28, 2024
We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.”BUFFALO, NY- August 28, 2024 – A new research paper was published in Oncotarget's Volume 15... read more